• Mashup Score: 0
    Pembrolizumab approved by FDA for cSCC - 5 year(s) ago

    The U.S. Food and Drug Administration has approved pembrolizumab for cutaneous squamous cell carcinoma whose disease has shown to not be curable by radiation or surgery.

    Source: Dermatology Times
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DermTimesNow
      DermTimesNow

      The @US_FDA has #approved pembrolizumab for cutaneous squamous cell carcinoma (cSCC) whose disease has shown to not be curable by radiation or surgery. https://t.co/ZtH2W3uzrh #FDAapproved #cSCC https://t.co/1rfikUyOKq